The 2nd Zhongshan Global Biotech Summit, with the theme of "Advances in Therapy of ALS and Rare Diseases", opened in Cuiheng New District on May 16.

Leading experts from home and abroad were invited to deliver keynote speeches and share innovative breakthroughs in AI-driven drug discovery, new drug development for rare diseases and others.

ZebraPeutics (Zhongshan) Ltd and Bethune Medical Development Association of Canada (BMDAC) signed a strategic cooperation agreement to jointly establish an international research collaboration platform.

The "Zebrafish Drug Screening Platform for Amyotrophic Lateral Sclerosis (ALS)" initiated by ZebraPeutics (Zhongshan) Ltd and ALS fighter Cai Lei's team was launched. This platform is expected to significantly boost the efficiency of ALS drug development.